Lensar (LNSR) Common Equity (2019 - 2026)
Lensar's (LNSR) quarterly Common Equity came in at $10.8 million in Q1 2026, up 148.73% year-on-year from $4.3 million in Q1 2025, and up 141.47% on a QoQ basis from -$26.0 million in Q4 2025.
Lensar (LNSR) Common Equity (2019 - 2026) Analysis & Trends
Lensar (LNSR) has 8 years of Common Equity data on file, last reported at $10.8 million in Q1 2026.
- On a quarterly basis, Common Equity rose 148.73% year-over-year to $10.8 million in Q1 2026; TTM through Mar 2026 was $10.8 million, a 148.73% increase from a year earlier, with the FY2025 full-year figure at -$26.0 million, down 635.15% from the prior year.
- Common Equity for Q1 2026 stood at $10.8 million, up from -$26.0 million in the prior quarter.
- Over the last five years, Common Equity for LNSR reached as high as $49.8 million in Q1 2022 and fell as low as -$26.0 million in Q4 2025.
- Historically, Common Equity has averaged $18.7 million across 5 years, with a median of $31.8 million in 2024.
- Across the five-year window, Common Equity slumped 635.15% in 2025 and jumped 148.73% in 2026, its largest moves.
- Year by year, Common Equity stood at $42.0 million in 2022, then declined by 20.38% to $33.4 million in 2023, then tumbled by 85.46% to $4.9 million in 2024, then slumped by 635.15% to -$26.0 million in 2025, then surged by 141.47% to $10.8 million in 2026.
- Per Business Quant data, the three most recent Common Equity figures were $10.8 million in Q1 2026, -$26.0 million in Q4 2025, and -$25.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 52.70 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 38.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 50.07 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 25.86 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 10.33 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.96 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 13.34 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 10.67 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 5.29 Bn |
| 10 | Lensar | 70.05 Mn | 72.73 Mn | 6.38 Mn | 10.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.79 Mn |
| Dec 31, 2025 | -26.02 Mn |
| Sep 30, 2025 | -25.91 Mn |
| Jun 30, 2025 | -23.05 Mn |
| Mar 31, 2025 | -22.14 Mn |
| Dec 31, 2024 | 4.86 Mn |
| Sep 30, 2024 | 22.74 Mn |
| Jun 30, 2024 | 23.65 Mn |
| Mar 31, 2024 | 31.84 Mn |
| Dec 31, 2023 | 33.43 Mn |
| Sep 30, 2023 | 36.38 Mn |
| Jun 30, 2023 | 32.69 Mn |
| Mar 31, 2023 | 39.44 Mn |
| Dec 31, 2022 | 41.98 Mn |
| Sep 30, 2022 | 42.58 Mn |
| Jun 30, 2022 | 44.90 Mn |
| Mar 31, 2022 | 49.81 Mn |
| Dec 31, 2021 | 54.88 Mn |
| Sep 30, 2021 | 57.05 Mn |
| Jun 30, 2021 | 61.63 Mn |